United States News Todas as matérias

United Airlines Holdings (NYSE:UAL) shares took flight in after-hours trading Tuesday after the carrier posted the highest quarterly revenue in its history, overcoming a costly government shutdown to deliver a significant earnings beat.

Netflix (NASDAQ:NFLX) shares dipped in after-hours trading Tuesday despite the streaming giant beating revenue expectations and crossing the 325-million subscriber milestone, as investors weighed the massive financial commitments of its pending Warner Bros. Discovery acquisition.

A broad selloff erased billions in market value Tuesday as investors retreated from high-flying technology stocks, spooked by President Trump’s escalating trade war threats against European allies.

Corvus Pharmaceuticals (NASDAQ:CRVS) shares skyrocketed more than 60% in early trading Tuesday after the company reported that its experimental oral therapy significantly cleared skin in patients with moderate-to-severe atopic dermatitis.

Viatris (NASDAQ:VTRS) has officially commenced the global expansion of its cardiovascular portfolio with the launch of Inpefa (sotagliflozin) in the United Arab Emirates, marking the first commercial availability of the therapy outside the United States.

MAIA-BIOTECH-2026-CLINICAL-OUTLOOK

Performance Shipping (NASDAQ:PSHG) secured a three-year charter agreement with PBF Energy, pushing its revenue backlog to an all-time high and reinforcing its strategy of locking in long-term cash flow amid a volatile global energy market.

Barnes & Noble Education (NYSE:BNED) shares rose Tuesday after the campus bookstore operator reported a return to profitability for its fiscal second quarter, driven by aggressive growth in its inclusive-access course material programs.

Phio Pharmaceuticals (NASDAQ:PHIO) reported that its experimental gene-silencing therapy cleared tumors in the majority of patients during a mid-stage study, marking a significant win for its proprietary INTASYL technology.

MSC Income Fund (NYSE:MAIN) signaled a strong finish to 2025, providing preliminary fourth-quarter results that point to rising asset values and double-digit returns on equity as it navigates a stabilizing interest rate environment.

ZOOZ Strategy (NASDAQ:ZOOZ) finished 2025 with a significantly bolstered balance sheet and a clean debt profile, reflecting the company’s aggressive transition from energy storage to a Bitcoin-anchored holding company.

Corporación América Airports (NYSE:CAAP) reported robust passenger growth for 2025, fueled by a surge in international travel and record-breaking performances in key markets.

Regentis Biomaterials (NYSE:RGNT) shares gained after new long-term imaging data showed its hydrogel implant successfully regenerated knee cartilage with a structural complexity nearly identical to healthy human tissue.

Celcuity (NASDAQ:CELC) shares rose in premarket trading Tuesday after the U.S. Food and Drug Administration accepted the New Drug Application for gedatolisib, a potential first-in-class therapy for patients with advanced breast cancer.

Dyne Therapeutics (NASDAQ:DYN) secured a regulatory win in Asia as Japanese authorities granted orphan drug status to its lead candidate for myotonic dystrophy, providing the biotech with a clear path toward market exclusivity in the world’s third-largest pharmaceutical market.

AmeriServ Financial (NASDAQ:ASRV) reported a sharp rise in fourth-quarter and full-year earnings, as significantly higher net interest income outweighed a multi-million dollar charge-off linked to a troubled commercial real estate loan.

Eli Lilly (NYSE:LLY) shares gained after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to its experimental antibody-drug conjugate, potentially accelerating the path to market for a treatment targeting hard-to-treat gynecologic cancers.

Fifth Third Bancorp (NASDAQ:FITB) reported fourth-quarter earnings that topped Wall Street expectations, driven by resilient lending activity and improved credit trends even as higher expenses weighed on efficiency.

Melbourne, Australia-based Telix Pharmaceuticals (NASDAQ:TLX) reported unaudited financial and operational highlights for the full year and fourth quarter ended December 31, 2025.

Boeing (NYSE:BA) secured a significant commitment from Ethiopian Airlines Group for 20 aircraft, as Africa's largest carrier moves to modernize its fleet and broaden its reach across four continents.

Novavax (NASDAQ:NVAX) shares rose in early trading after the company reached an agreement to license its vaccine-boosting technology to Pfizer (NYSE;PFE), providing a fresh source of capital for the Maryland-based biotech.

Fastenal (NASDAQ:FAST) met Wall Street’s fourth-quarter expectations for both profit and revenue, signaling resilience in the industrial supply sector despite a cooling macro environment.

Netflix (NYSE:WBD) and Warner Bros. Discovery (NYSE:WBD) amended their definitive merger agreement on Tuesday, pivoting to an all-cash transaction to provide shareholders with greater price protection and accelerate the closing timeline.

Forestar Group (NYSE:FOR) reported fiscal first-quarter results on Tuesday that aligned with analyst expectations, balancing a modest decline in bottom-line profit with a steady increase in top-line revenue.